How strongly does tissue decelerate the therapeutic heavy ion beam?
7/17/2014
PTB has developed a method for the more exact dosing of heavy ion irradiation in the case of cancer.
Possible new type of immunotherapy: molecular 'eat now' signal makes cells devour dying neighbors
7/17/2014
A team of researchers has devised a Pac-Man-style power pellet that gets normally mild-mannered cells to gobble up their undesirable neighbors.
Potential new approach to brain cancer treatments and a better understanding of Parkinson's disease
7/17/2014
Researchers at the UNC School of Medicine have discovered that the protein PARC/CUL9 helps neurons and brain cancer cells override the biochemical mechanisms that lead to cell death in most other...
New UK online video diary programme "Cancerstories" offers hope to patients and families with cancer
7/17/2014
A new innovation that aims to provide hope and inspiration for those newly diagnosed with cancer - and people with a past diagnosis - is to launch today (Thursday 17 July).
A powerful new technique for early diagnosis of cancer
7/17/2014
Despite impressive medical strides, cancer remains a leading killer and overwhelming burden to healthcare systems, causing well over a half million fatalities per year with a projected cost of $174...
Tumor growth and metastasis controlled by new drug combo in mouse model
7/17/2014
Researchers at UC Davis, University of Massachusetts and Harvard Medical School have created a combination drug that controls both tumor growth and metastasis.
Best anticoagulants after orthopedic procedures depends on type of surgery
7/17/2014
Current guidelines do not distinguish between aspirin and more potent blood thinners for protecting against blood clots in patients who undergo major orthopedic operations, leaving the decision up...
Prostate cancer is focus of two studies in JAMA Internal Medicine
7/16/2014
Management for Low-Risk Prostate Cancer Varies Widely Among Physicians Management of low-risk prostate cancer (which is unlikely to cause symptoms or affect survival if left untreated) varies...
CellAct Pharma receives orphan drug designation in EU for CAP7.1 in biliary tract cancers
7/16/2014
CellAct Pharma, a developer of innovative treatments for cancer, has announced that the Committee for Orphan Medicinal Products of the European Medicines Agency (EMA) has granted orphan drug...
Boehringer Ingelheim has announced that Pradaxa® will be commercially available in the UK for the treatment of DVT and PE and the prevention of recurrent DVT and PE in adults, from today (July...